Antidote to synthetic cannabis 'Spice' intoxication could be found in slimming drug

October 4, 2017, Queen Mary, University of London

Early research from Queen Mary University of London has potentially found an antidote that can rapidly stop the intoxicating effects of cannabis and synthetic cannabinoids.

Synthetic cannabinoids, such as 'Spice' and 'Black Mamba', are becoming an increasing problem, especially with youths game to experiment and within the homeless and prison populations, due to their cheapness and odourless properties. Their super strength compared to cannabis is leading to an increasing number of severe adverse reactions and an increasing number of deaths.

The study, published in the British Journal of Pharmacology, looked at mice that were experiencing the effects of synthetic cannabinoid intoxication, to see the effects of treating them with a molecule known as AM251.

AM251 blocked the action of the synthetic cannabinoid on one of the and led to a loss of the cannabinoid-related behavioural effects within a few minutes. This included a significant loss of sedation within 20 minutes, and a loss of the associated hypothermia within 40 minutes.

The researchers say that the most rapid way to develop an antidote would be to re-develop one of the slimming drugs, known as rimonabant, which also blocks the system on which marijuana acts.

Explore further: Cannabinoids induce seizures by acting through the cannabinoid CB1 receptor

More information: Gareth Pryce et al, Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB-13, in mice, British Journal of Pharmacology (2017). DOI: 10.1111/bph.13973

Related Stories

Cannabinoids induce seizures by acting through the cannabinoid CB1 receptor

September 21, 2017
Marijuana is the most commonly abused drug in the world, and the advent of synthetic cannabinoids creates additional challenges to society because of their higher potency and ability to escape drug detection screenings. Scientists ...

Increase in acute synthetic cannabinoid poisonings

July 15, 2016
(HealthDay)—Synthetic cannabinoids are sending increasing numbers of U.S. users to hospitals, according to research published in the July 15 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality ...

Genetic factors may contribute to adverse effects produced by synthetic cannabinoids

April 24, 2017
Synthetic cannabinoid abuse is a growing problem in the United States, with new versions of the drugs coming on the market every year. New research is examining how the body processes these man-made drugs and the role that ...

Synthetic cannabinoids versus natural marijuana—a comparison of expectations

April 27, 2016
An article entitled "Comparison of Outcome Expectancies for Synthetic Cannabinoids and Botanical Marijuana," from The American Journal of Drug and Alcohol Abuse, studied the expected outcomes of both synthetic and natural ...

Canada should continue with separate medical stream after cannabis is legalized for recreational use

July 17, 2017
After cannabis is legalized, Canada should continue with a separate medical cannabis stream to keep patients safe, argues a commentary in CMAJ (Canadian Medical Association Journal)

A look at the 'marijuana' receptor

October 20, 2016
Researchers have the clearest picture yet of the receptor that causes the "high" associated with marijuana. The three-dimensional image of cannabinoid receptor 1, revealed October 20 in Cell, reveals how molecules like THC ...

Recommended for you

Enzyme identified as possible novel drug target for sickle cell disease, Thalassemia

July 19, 2018
Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease (SCD). Experiments ...

Mice given metabolite succinate found to lose weight by turning up the heat

July 19, 2018
A team of researchers with members from institutions across the U.S. and Canada has found that giving the metabolite succinate to mice fed a high-fat diet prevented obesity. In their paper published in the journal Nature, ...

Supplement may ease the pain of sickle cell disease

July 19, 2018
(HealthDay)—An FDA-approved supplement reduces episodes of severe pain in people with sickle cell disease, a new clinical trial shows.

Scientists uncover DNA 'shield' with crucial roles in normal cell division

July 18, 2018
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

Researchers develop novel bioengineering technique for personalized bone grafts

July 18, 2018
Scientists from the New York Stem Cell Foundation (NYSCF) Research Institute have developed a new bone engineering technique called Segmental Additive Tissue Engineering (SATE). The technique, described in a paper published ...

Researchers report protein kinase as the switch controlling obesity and diabetes

July 18, 2018
One of the research lines targeting the worldwide obesity epidemic is the manipulation of brown adipose tissue, a 'good' type of fat that burns lipids to maintain an appropriate body temperature. Researchers at the Centro ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.